Zhang et al[25] also showed that Roxadustat could upregulate HIF-2-α in adipocytes, increasing both the excretion of liver cholesterol and reducing the plasma cholesterol level, and thus having a protective effect on atherosclerosis. The gene discussed is EPAS1; the disease is atherosclerosis.